Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07190495

Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy

Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
102 (estimated)
Sponsor
University Tunis El Manar · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.

Conditions

Interventions

TypeNameDescription
DRUGGingerPatients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy
DRUGPlaceboPatients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy

Timeline

Start date
2025-07-05
Primary completion
2026-06-01
Completion
2026-12-01
First posted
2025-09-24
Last updated
2025-09-24

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT07190495. Inclusion in this directory is not an endorsement.

Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy (NCT07190495) · Clinical Trials Directory